Bimiralisib (PQR309)

Ask supplier a question | View on supplier's website

Bimiralisib (PQR309) is a novel brain-penetrant dual PI3K/mTOR inhibitor with in vitro and in vivo antilymphoma activity. It displays excellent selectivity versus PI3K-related lipid kinases, protein kinases and unrelated targets.

Supplier	Selleck Chemicals
Product #	S8738
Sku #	S8738-100mg
Pricing	100mg, $870.00

Feedback